Ethinylestradiol/norelgestromin

Ethinylestradiol/norelgestromin, sold under the brand name Ortho Evra among others, is a contraceptive patch containing the estrogen ethinylestradiol and the progestin norelgestromin which is marketed in the United States, Canada, Europe, and elsewhere in the world.[1] As of December 2016, the product Ortho Evra has been discontinued in the U.S. while the product Xulane continues to be marketed. [1]

Ethinylestradiol/norelgestromin
Combination of
EthinylestradiolEstrogen
NorelgestrominProgestogen
Clinical data
Trade namesOrtho Evra, Xulane, Twirla
AHFS/Drugs.comMultum Consumer Information
MedlinePlusa602006
License data
Pregnancy
category
  • US: N (Not classified yet)
  • Contraindicated
Routes of
administration		Transdermal (patch)
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
  • None
UNII
KEGG
Main article: Contraceptive patch

See also

References
  1. "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 22 December 2016.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.